These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12761262)

  • 1. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease.
    Tonelli M; Moyé L; Sacks FM; Cole T; Curhan GC;
    J Am Soc Nephrol; 2003 Jun; 14(6):1605-13. PubMed ID: 12761262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
    Tonelli M; Isles C; Craven T; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; West M; Packard C; Curhan GC
    Circulation; 2005 Jul; 112(2):171-8. PubMed ID: 15998677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of inflammation and progression of chronic kidney disease.
    Tonelli M; Sacks F; Pfeffer M; Jhangri GS; Curhan G;
    Kidney Int; 2005 Jul; 68(1):237-45. PubMed ID: 15954913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.
    Tonelli M; Moyé L; Sacks FM; Kiberd B; Curhan G;
    Ann Intern Med; 2003 Jan; 138(2):98-104. PubMed ID: 12529091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
    Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
    Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
    Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
    Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
    Deedwania PC; Stone PH; Fayyad RS; Laskey RE; Wilson DJ
    Drugs Aging; 2015 Dec; 32(12):1055-65. PubMed ID: 26625880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin and cardiovascular risk in moderate chronic kidney disease.
    Nakamura H; Mizuno K; Ohashi Y; Yoshida T; Hirao K; Uchida Y;
    Atherosclerosis; 2009 Oct; 206(2):512-7. PubMed ID: 19423108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for improving renal outcomes: a meta-analysis.
    Sandhu S; Wiebe N; Fried LF; Tonelli M
    J Am Soc Nephrol; 2006 Jul; 17(7):2006-16. PubMed ID: 16762986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of glomerular filtration rate based on the modification of diet in renal disease equation in patients with chronic renal failure.
    Schuck O; Teplan V; Marecková O; Skibová J; Stollová M
    Kidney Blood Press Res; 2005; 28(2):63-7. PubMed ID: 15640609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin-induced arrest in progression of renal disease.
    Vidt DG; Cressman MD; Harris S; Pears JS; Hutchinson HG
    Cardiology; 2004; 102(1):52-60. PubMed ID: 15073451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Dec; 7(12):2616-26. PubMed ID: 8989740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between women and men with chronic renal disease.
    Coggins CH; Breyer Lewis J; Caggiula AW; Castaldo LS; Klahr S; Wang SR
    Nephrol Dial Transplant; 1998 Jun; 13(6):1430-7. PubMed ID: 9641172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: the third National Health and Nutrition Examination Survey and United States Renal Data System.
    Trivedi HS; Pang MM
    Am J Nephrol; 2003; 23(6):448-57. PubMed ID: 14583664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Coombes JS
    Atherosclerosis; 2010 Nov; 213(1):218-24. PubMed ID: 20810109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function.
    MacIsaac RJ; Ekinci EI; Premaratne E; Lu ZX; Seah JM; Li Y; Boston R; Ward GM; Jerums G
    BMC Nephrol; 2015 Dec; 16():198. PubMed ID: 26630928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between two routine methods of estimation of glomerular filtration rate in patients with advanced and terminal chronic renal failure.
    Garcia-Naveiro R; Rodriguez-Carmona A; Pérez-Fontán M
    Clin Nephrol; 2005 Oct; 64(4):271-80. PubMed ID: 16240898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.